Evidence map›Paper›PMID 39279323›Full record

ArticleClinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Correlation Between Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio with Risk Stratification Indicators and Thrombus Burden in Patients with Moderate-to-High Risk Acute Pulmonary Embolism, and Changes After Treatment.

Xiaojie Gao, Huang Chen, Zhongjie Huang, Jianxiong Lin, Jinqi Huang, Qihong Chen

Abstract read
In one paragraph

Article in Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xiaojie GaoDepartment of Interventional Vascular Surgery, The First Hospital of Putian City, Teaching Hospital, Fujian Medical University, Putian, Fujian Province, People's Republic of China.
Huang ChenDepartment of Interventional Vascular Surgery, The First Hospital of Putian City, Teaching Hospital, Fujian Medical University, Putian, Fujian Province, People's Republic of China.
Zhongjie HuangDepartment of Interventional Vascular Surgery, The First Hospital of Putian City, Teaching Hospital, Fujian Medical University, Putian, Fujian Province, People's Republic of China.
Jianxiong LinDepartment of Interventional Vascular Surgery, The First Hospital of Putian City, Teaching Hospital, Fujian Medical University, Putian, Fujian Province, People's Republic of China.
Jinqi HuangDepartment of Interventional Vascular Surgery, The First Hospital of Putian City, Teaching Hospital, Fujian Medical University, Putian, Fujian Province, People's Republic of China.
Qihong ChenDepartment of Interventional Vascular Surgery, The First Hospital of Putian City, Teaching Hospital, Fujian Medical University, Putian, Fujian Province, People's Republic of China.ORCID 0009-0006-2235-3757

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the correlation between neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and risk stratification indicators as well as thrombus burden in patients with moderate-to-high risk acute pulmonary embolism (APE), and to assess the changes in these parameters following interventional therapy.

methodsThis study retrospectively included patients with moderate-to-high risk APE who were admitted to the Department of Interventional Vascular Surgery at Putian First Hospital from May 2020 to May 2024. All patients received anticoagulation therapy, pulmonary artery catheter-directed thrombolysis, and/or mechanical thrombectomy. Patients were further divided into subgroup A if they did not present with any of the following conditions at admission: a) acute inflammatory diseases (including lung infections); b) malignant tumors; c) history of trauma or surgery within the past 2 months. Patients with any of the aforementioned conditions were classified as subgroup B. Additionally, 50 healthy individuals were randomly selected as the healthy control group.

resultsThe NLR and PLR in subgroup A were significantly lower than those in subgroup B (

conclusionElevated NLR in patients with APE, which decreases after effective treatment, may be used for assessing disease status and treatment efficacy. However, there is no correlation between NLR and risk stratification indicators or thrombus burden. PLR does not demonstrate significant value in assessing APE.

Indexed as

Blood PlateletsLymphocytesNeutrophilsPulmonary EmbolismAcute DiseaseAdultAgedFemaleHumansMaleMiddle AgedRetrospective StudiesRisk AssessmentThrombosisacute pulmonary embolismneutrophil-to-lymphocyte ratioplatelet-to-lymphocyte ratiorisk stratificationthrombus burden

Identifiers

PMID39279323
PMCPMC11406580

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.